{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T16:51:56Z","timestamp":1791046316959,"version":"4.1.0"},"reference-count":14,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":927,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1111\/bjd.12133","type":"journal-article","created":{"date-parts":[[2013,2,18]],"date-time":"2013-02-18T10:11:59Z","timestamp":1361182319000},"page":"726-732","source":"Crossref","is-referenced-by-count":115,"title":["Prognosis of generalized bullous fixed drug eruption: comparison with Stevens-Johnson syndrome and toxic epidermal necrolysis"],"prefix":"10.1093","volume":"168","author":[{"given":"S.","family":"Lipowicz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Sekula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Ingen-Housz-Oro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Liss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Sassolas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Dunant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-C.","family":"Roujeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Mockenhaupt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,2,16]]},"reference":[{"key":"10.1111\/bjd.12133-BIB1|cit1","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1365-2133.1985.tb15266.x","article-title":"Fixed eruptions: causative drugs and challenge tests","volume":"112","author":"Kauppinen","year":"1985","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12133-BIB2|cit2","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1365-4362.1988.tb04923.x","article-title":"Widespread bullous fixed drug eruption mimicking toxic epidermal necrolysis","volume":"27","author":"Baird","year":"1988","journal-title":"Int J Dermatol"},{"key":"10.1111\/bjd.12133-BIB3|cit3","first-page":"572","article-title":"Clinical resemblance of widespread bullous fixed drug eruption to Stevens-Johnson syndrome or toxic epidermal necrolysis: report of two cases","volume":"101","author":"Lin","year":"2002","journal-title":"J Formos Med Assoc"},{"key":"10.1111\/bjd.12133-BIB4|cit4","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1365-2133.1956.tb12766.x","article-title":"Toxic epidermal necrolysis: an eruption resembling scalding of the skin","volume":"68","author":"Lyell","year":"1956","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12133-BIB5|cit5","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/j.1365-2133.1990.tb06275.x","article-title":"Requiem for toxic epidermal necrolysis","volume":"122","author":"Lyell","year":"1990","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12133-BIB6|cit6","volume-title":"Fitzpatrick\u2019s Dermatology in General Medicine","author":"Valeyrie-Allanore","year":"2007"},{"key":"10.1111\/bjd.12133-BIB7|cit7","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000104186","volume-title":"Drug Hypersensitivity","author":"Mockenhaupt","year":"2007"},{"key":"10.1111\/bjd.12133-BIB8|cit8","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/ACI.0b013e32832cda4c","article-title":"Fixed drug eruption: pathogenesis and diagnostic tests","volume":"9","author":"Shiohara","year":"2009","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1111\/bjd.12133-BIB9|cit9","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1523-1747.2000.00061.x","article-title":"SCORTEN: a severity-of-illness score for toxic epidermal necrolysis","volume":"115","author":"Bastuji-Garin","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.12133-BIB10|cit10","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/sj.jid.5701033","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR study","volume":"128","author":"Mockenhaupt","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.12133-BIB11|cit11","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/BCR.0b013e31820aafbc","article-title":"Evaluation of SCORTEN on a cohort of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis included in the RegiSCAR study","volume":"32","author":"Sekula","year":"2011","journal-title":"J Burn Care Res"},{"key":"10.1111\/bjd.12133-BIB12|cit12","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","article-title":"Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme","volume":"129","author":"Bastuji-Garin","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.12133-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1001\/archderm.138.8.1019","article-title":"Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study","volume":"138","author":"Auquier-Dunant","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.12133-BIB14|cit14","first-page":"4","article-title":"Introducing a novel Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) in pemphigus","volume":"17","author":"Pf\u00fctze","year":"2007","journal-title":"Eur J Dermatol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.12133","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.12133\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T09:03:31Z","timestamp":1676365411000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/168\/4\/726\/6614285"}},"subtitle":["Prognosis of GBFDE vs. SJS\/TEN"],"short-title":[],"issued":{"date-parts":[[2013,2,16]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.12133","relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2,16]]}}}